project id: TCGA-STAD; case submitter id: TCGA-VQ-A94U; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.57; rna integrity number: 7.0; age at index: 70; days to birth: -25925; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 25925; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 819.0; icd 10 code: C16.3; last known disease status: not reported; morphology: 8490/3; primary diagnosis: Signet ring cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Gastric antrum; synchronous malignancy: No; tissue or organ of origin: Gastric antrum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 458; days to sample procurement: 0; initial weight: 170.0; portion submitter id: TCGA-VQ-A94U-01A-12; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 79.0; percent tumor nuclei: 96.0;